DB18195InvestigationalProtein Based Therapies
Canoctakin: Overview.
- Also known as
- Glycafilin · Interleukin 8 (synthetic human clone dncxcl8 increased-glycosaminoglycan binding isoform pa401) · Recombinant dna derived, human interleukin 8 (cxcl8) mutein, produced in escherichia coli: (44,48,97,98-tetra-l-lysine)human interleukin 8 precursor-(34-99)- peptide anti-inflammatory
- Code names
- PA-401
Resolves to
Compound
What you can answer from here — as of September 15, 2023
Which companies are running trials of Canoctakin, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account